Results 101 to 110 of about 11,699 (159)

Updated Burden and Long‐Term Projections of Chronic Hepatitis B and C in Japan: A Nationwide Markov Modeling Study

open access: yesHepatology Research, Volume 56, Issue 8, Page 1213-1224, August 2026.
ABSTRACT Aim Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections remain major causes of liver‐related morbidity and mortality worldwide. Although Japan has implemented nationwide screening and treatment programs for decades, updated nationwide estimates and long‐term projections are limited.
Junko Tanaka   +4 more
wiley   +1 more source

Efficacy and safety of pyrimidine nucleos(t)ide therapy in thymidine kinase 2 deficiency. [PDF]

open access: yesBrain Commun
Hirano M   +9 more
europepmc   +1 more source

Spatial Scale Modulates the Effect of Habitat Amount on Diversity Patterns of Arachnid Assemblages Across Different Brazilian Ecosystems

open access: yesJournal of Biogeography, Volume 53, Issue 8, August 2026.
ABSTRACT Aim We evaluated how native vegetation cover influences the diversity of arachnid assemblages across multiple spatial scales in major Brazilian ecosystems. Location Brazil (Amazon and Atlantic rainforests, Cerrado savanna and Caatinga dry forest). Taxon Arachnida (Opiliones, Pseudoscorpiones and Scorpiones). Methods We sampled arachnids at 120
André F. A. Lira   +26 more
wiley   +1 more source

Outcomes of Nucleos(t)ide Analogue Discontinuation in Noncirrhotic Patients With Chronic Hepatitis B: A Retrospective Study. [PDF]

open access: yesCureus
Bhatt S   +8 more
europepmc   +1 more source

The Silent Burden of Hepatitis B‐Related Stigma

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 8, August 2026.
ABSTRACT Individuals experiencing stigma related to chronic hepatitis B virus (HBV) infection often experience negative self‐beliefs, isolation, discrimination, and reduced willingness to engage with healthcare professionals. We aimed to understand the patient perspective of HBV‐related stigma and to summarize the patient experience of stigma in a ...
Verity Smith   +6 more
wiley   +1 more source

Monocyte-derived IL-1β predicts and promotes HBsAg decline in chronic hepatitis B patients under nucleoside analogue therapy. [PDF]

open access: yesHepatol Commun
Shigeno S   +15 more
europepmc   +1 more source

From Diagnosis to Durability: A Review of the European Bulevirtide Experience and Practical Learnings for CHD Management

open access: yesLiver International, Volume 46, Issue 8, August 2026.
ABSTRACT Hepatitis delta virus (HDV) infection causes chronic hepatitis D (CHD), the most severe form of chronic viral hepatitis with a high risk of progression to advanced liver disease. Off‐label pegylated interferon alpha was the primary treatment option in Europe prior to the introduction of bulevirtide, a first‐in‐class HDV entry inhibitor.
Monica Radu   +11 more
wiley   +1 more source

Emerging Immune‐Based Therapeutic Strategies in Hepatocellular Carcinoma

open access: yesLiver International, Volume 46, Issue 8, August 2026.
ABSTRACT Hepatocellular carcinoma (HCC) remains a leading cause of cancer‐related mortality worldwide despite recent advances in systemic therapy. The introduction of immune checkpoint inhibitors has substantially expanded treatment options for advanced disease; however, durable responses are observed only in a subset of patients.
Janine Kah   +2 more
wiley   +1 more source

High Rates of Advanced Chronic Liver Disease in Patients With Chronic Hepatitis D Virus Infection in Uzbekistan

open access: yesLiver International, Volume 46, Issue 8, August 2026.
ABSTRACT Background and Aims Chronic hepatitis B virus (HBV) infection is endemic in Uzbekistan. Previous data showed a high prevalence of anti‐hepatitis D virus (HDV) antibodies in HBsAg‐positive individuals. Limited data are available on disease severity, treatment availability and hepatocellular carcinoma (HCC) prevalence in patients with chronic ...
Malika E. Khodjaeva   +12 more
wiley   +1 more source

Laparoscopic or Open Liver Resection Versus Multibipolar Radiofrequency Ablation of HCC Within Milan Criteria on Cirrhosis

open access: yesLiver International, Volume 46, Issue 8, August 2026.
ABSTRACT Background & Aims We compared multibipolar radiofrequency ablation (mbpRFA) with open liver resection (OLR) or laparoscopic liver resection (LLR) in patients with HCCs within Milan. Methods This multicenter cohort study included patients treated by mbpRFA, OLR or LLR for HCC within the Milan Criteria, developed on advanced fibrosis in nine ...
Christian Hobeika   +25 more
wiley   +1 more source

Home - About - Disclaimer - Privacy